TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 41 filers reported holding TCR2 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $467,000 | -38.0% | 259,672 | 0.0% | 0.01% | -33.3% |
| Q2 2022 | $753,000 | +5.0% | 259,672 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $717,000 | -64.1% | 259,672 | -39.3% | 0.01% | -62.5% |
| Q4 2021 | $1,995,000 | -80.7% | 428,088 | -64.7% | 0.02% | -80.2% |
| Q3 2021 | $10,327,000 | -38.7% | 1,213,498 | +18.1% | 0.08% | -36.2% |
| Q2 2021 | $16,855,000 | -20.8% | 1,027,128 | +6.6% | 0.13% | -20.1% |
| Q1 2021 | $21,276,000 | -41.1% | 963,606 | -17.4% | 0.16% | -43.2% |
| Q4 2020 | $36,102,000 | +45.4% | 1,167,220 | -4.5% | 0.28% | +18.1% |
| Q3 2020 | $24,825,000 | +19.2% | 1,221,699 | -9.9% | 0.24% | +10.2% |
| Q2 2020 | $20,828,000 | +97.5% | 1,356,010 | -0.5% | 0.22% | +55.8% |
| Q1 2020 | $10,547,000 | -41.8% | 1,362,653 | +7.3% | 0.14% | -14.3% |
| Q4 2019 | $18,132,000 | +7.1% | 1,269,766 | +12.7% | 0.16% | -4.7% |
| Q3 2019 | $16,928,000 | +143.7% | 1,126,307 | +132.1% | 0.17% | +152.2% |
| Q2 2019 | $6,945,000 | -15.3% | 485,332 | +3.1% | 0.07% | -13.0% |
| Q1 2019 | $8,204,000 | – | 470,698 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |